Risk of developing antiphospholipid antibodies following viral infection: a systematic review and meta-analysis
Objective The objective of this paper is to conduct a systematic review and meta-analysis on
the risk of developing elevated antiphospholipid (aPL) antibodies and related …
the risk of developing elevated antiphospholipid (aPL) antibodies and related …
Manifestations of chronic hepatitis C virus infection beyond the liver
IM Jacobson, P Cacoub, L Dal Maso… - Clinical …, 2010 - Elsevier
In addition to its effects in the liver, chronic hepatitis C virus (HCV) infection can have serious
consequences for other organ systems. Extrahepatic manifestations include mixed …
consequences for other organ systems. Extrahepatic manifestations include mixed …
Role of infectious diseases in the antiphospholipid syndrome (including its catastrophic variant)
C Mendoza-Pinto, M García-Carrasco… - Current rheumatology …, 2018 - Springer
Abstract Purpose of Review The antiphospholipid syndrome (APS) is characterized by the
development of thrombotic events and pregnancy morbidity in the presence of …
development of thrombotic events and pregnancy morbidity in the presence of …
Antiphospholipid antibodies, antiphospholipid syndrome and infections
D Sène, JC Piette, P Cacoub - Autoimmunity reviews, 2008 - Elsevier
Since the association between antiphospholipid antibodies (aPL) and syphilis was first
described, many other viral, bacterial and parasitic infections have been shown to induce …
described, many other viral, bacterial and parasitic infections have been shown to induce …
Viral infection can induce the production of autoantibodies
O Barzilai, M Ram, Y Shoenfeld - Current opinion in rheumatology, 2007 - journals.lww.com
Viral infection can induce the production of autoantibodies : Current Opinion in Rheumatology
Viral infection can induce the production of autoantibodies : Current Opinion in Rheumatology …
Viral infection can induce the production of autoantibodies : Current Opinion in Rheumatology …
Hepatitis C virus-associated extrahepatic manifestations: a review
D Sène, N Limal, P Cacoub - Metabolic brain disease, 2004 - Springer
The hepatitis C virus (HCV) infection is a worldwide disease that is characterized by a
preferential chronic evolution with mild to severe liver disease, including cirrhosis and, in …
preferential chronic evolution with mild to severe liver disease, including cirrhosis and, in …
Hepatitis B virus (HBV) and autoimmune disease
R Maya, ME Gershwin, Y Shoenfeld - Clinical reviews in allergy & …, 2008 - Springer
The etiology and pathogenesis of autoimmune diseases have long been an enigmatic
subject that have involved genetic and environmental factors. Recent intriguing data has …
subject that have involved genetic and environmental factors. Recent intriguing data has …
[HTML][HTML] Thrombocytopenia in patients with chronic hepatitis C virus infection
S Dahal, S Upadhyay, R Banjade… - … journal of hematology …, 2017 - ncbi.nlm.nih.gov
Thrombocytopenia in patients with chronic hepatitis C virus (HCV) infection is a major
problem. The pathophysiology is multifactorial, with auto-immunogenicity, direct bone …
problem. The pathophysiology is multifactorial, with auto-immunogenicity, direct bone …
Prevalence of thrombocytopenia among patients with chronic hepatitis C: a systematic review
KS Louie, JM Micallef, JM Pimenta… - Journal of viral …, 2011 - Wiley Online Library
Thrombocytopenia (TCP) is a haematological condition known to occur in chronically
infected hepatitis C (HCV) patients and may interfere with diagnostic procedures, such as …
infected hepatitis C (HCV) patients and may interfere with diagnostic procedures, such as …
Hepatitis C virus-associated B-cell proliferation—the role of serum B lymphocyte stimulator (BLyS/BAFF)
Objective. B lymphocyte stimulator (BLyS) is known to support B-cell proliferation (BCP) in B-
cell haemopathies and autoimmune diseases. We assume that BLyS may play a role in the …
cell haemopathies and autoimmune diseases. We assume that BLyS may play a role in the …